CIK: 0001884931 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value ($000): $219,608 (92.4% shares, 7.6% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABUS | ARBUTUS BIOPHARMA CORP | 12,867,967 | $49,542 | 22.6% | $2.39 | +60.3% | COM | 03879J100 |
| — | ENDEAVOR GROUP HLDGS INC | 1,000,000 | $28,560 | 13.0% | $28.56 | — | CL A COM | 29260Y109 |
| ROIV | ROIVANT SCIENCES LTD | 2,391,000 | $27,592 | 12.6% | $10.09 | +12.8% | SHS | G76279101 |
| JOYY | JOYY INC | 565,878 | $20,507 | 9.3% | $33.95 | — | ADS REPSTG COM A | 46591M109 |
| GNW | GENWORTH FINL INC | 2,986,960 | $20,461 | 9.3% | $5.50 | +19.6% | COM SHS | 37247D106 |
| LQDA | LIQUIDIA CORPORATION | 1,702,025 | $17,020 | 7.8% | $11.21 | -2.5% | COM NEW | 53635D202 |
| CORZ | CORE SCIENTIFIC INC NEW | 1,147,500 | $13,609 | 6.2% | $9.16 | +13.1% | COM | 21874A106 |
| GSL | GLOBAL SHIP LEASE INC NEW | 366,771 | $9,774 | 4.5% | $19.36 | +32.6% | COM CL A | Y27183600 |
| NN | NEXTNAV INC | 1,252,831 | $9,384 | 4.3% | $3.61 | +114.0% | COMMON STOCK | 65345N106 |
| — | ESPERION THERAPEUTICS INC NE | 8,000,000 | $7,590 | 3.5% | $0.75 | — | NOTE 4.000%11/1 | 29664WAB1 |
| — | SABRE GLBL INC | 5,000,000 | $4,970 | 2.3% | $0.93 | — | NOTE 4.000% 4/1 | 78573NAE2 |
| — | INNOVATE CORP | 12,218,000 | $4,096 | 1.9% | $0.51 | — | NOTE 7.500% 8/0 | 404139AG2 |
| — | MAIDEN HOLDINGS LTD | 2,048,163 | $3,625 | 1.7% | $2.08 | — | SHS | G5753U112 |
| NNAVW | NEXTNAV INC | 482,951 | $1,401 | 0.6% | $1.42 | — | *W EXP 99/99/999 | 65345N114 |
| VATE | INNOVATE CORP | 320,131 | $1,184 | 0.5% | $4.94 | 0.0% | COM NEW | 45784J303 |
| OPK | OPKO HEALTH INC | 134,490 | $200 | 0.1% | $1.30 | +14.5% | COM | 68375N103 |
| TRIB | TRINITY BIOTECH PLC | 81,902 | $90 | 0.0% | $2.04 | — | SPONS ADR NEW | 896438504 |
| AEAEW | ALTENERGY ACQUISITION CORP | 186,315 | $2 | 0.0% | $0.23 | — | *W EXP 10/29/202 | 02157M116 |